HER2-targeting peptide-drug conjugate (PeptiDream)

N/A

Report date: 2025/01/26 18:35:22

Base Information

Drug NameHER2-targeting peptide-drug conjugate (PeptiDream)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeptiDream Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A